Avidro 1.5 is a medicine used for the prevention of migraine. However, it cannot treat an acute attack and will only work to prevent migraines for as lo... View More
Uses of Avidro 1.5
Side effects of Avidro 1.5
How to use Avidro 1.5
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Avidro 1.5 may be taken wi... View More
How Avidro 1.5 works
Migraine headaches are thought to result from the dilatation of blood vessels in the head. Avidro 1.5 is a serotonin antagonist. It works by maintaining... View More
What if you forget to take Avidro 1.5?
If you miss a dose of Avidro 1.5, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to you... View More
May be taken with or without food.
Oral Prophylaxis of migraine; Prophylaxis of cluster headache Adult: Initially, 0.5 mg, increase gradually as necessary. Maintenance: 1.5 mg daily a... View More
Oral Prophylaxis of migraine; Prophylaxis of cluster headache Child: >2 yr Initially, 0.5 mg. May increase gradually up to 1.5 mg daily in divided dos... View More
Renal impairment: Dose adjustment may be needed.
Premature infants or neonates. Postural giddiness.
Mode of Action
Pizotifen is a sedating antihistamine with strong serotonin antagonist and weak antimuscarinic properties. It also antagonises the action of tryptamine.... View More
Patient w/ angle-closure glaucoma, urinary retention, epilepsy. Avoid abrupt withdrawal. Renal and hepatic impairment. Childn. Pregnancy and lactation. ... View More
Increased appetite, nausea, wt gain, drowsiness, dizziness, dry mouth, fatigue, muscle pain or cramps, heavy or restless legs, fluid retention, facial f... View More
Enhances sedative effects of CNS depressants. Additive antimuscarinic action with other antimuscarinic drugs. May mask warning signs of damage caused by... View More
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More